UTHEVER® NMN: The Only NMN to Receive EFSA Positive Safety Opinion for Novel Food
July 2026
Access the UTHEVER® NMN white paper to discover this anti-ageing ingredient’s technical advantages & official compliance documents, including FDA NDI clearance in the U.S. and a positive EFSA safety opinion in Europe – the first-ever EU official safety endorsement for NMN. Learn the recommended safe daily intake of NMN as assessed by regulatory authorities in the white paper. Next, UTHEVER® NMN will be added to the EU Novel Food list, helping brands accelerate early market entry with strong regulatory support.
This Technical Paper is brought to you by EffePharm Ltd.
Brain & Mental Health
DolCas Biotech debuts Curcugen curcumin in Mānuka honey and cognitive drink
Nutraceutical supplier DolCas Biotech has introduced its Curcugen “full-spectrum” curcuminoid complex in two new functional applications. These are a Body Recovery & Gut honey supplied by New Zealand-based Mānukora and Numin, a...
Brain & Mental Health
Consumer study links Thorne’s Creatine + Alpha-GPC to focus and energy gains
An open-label consumer study conducted by Thorne indicates that adults supplementing with the company’s Creatine + Alpha-GPC (alpha-glycerylphosphorylcholine) product for 30 days reported improved outcomes in better focus, mental...
Brain & Mental Health
CPHI Milan 2026: ThreoTech spotlights Magtein for cognition, eyes new categories
ThreoTech will spotlight its patented magnesium ingredient, Magtein, at CPHI Milan next month (Oct 6–8). The company shares that the ingredient is known for supporting cognitive health, but new studies are exploring applications...
